199 related articles for article (PubMed ID: 34738707)
21. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.
Koorella C; Nair JR; Murray ME; Carlson LM; Watkins SK; Lee KP
J Biol Chem; 2014 Mar; 289(11):7747-62. PubMed ID: 24415757
[TBL] [Abstract][Full Text] [Related]
22. The landscape of
de Vos L; Grünwald I; Bawden EG; Dietrich J; Scheckenbach K; Wiek C; Zarbl R; Bootz F; Landsberg J; Dietrich D
Epigenetics; 2020 Nov; 15(11):1195-1212. PubMed ID: 32281488
[TBL] [Abstract][Full Text] [Related]
23. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.
Fargeas CA; Truneh A; Reddy M; Hurle M; Sweet R; Sékaly RP
J Exp Med; 1995 Sep; 182(3):667-75. PubMed ID: 7544393
[TBL] [Abstract][Full Text] [Related]
24. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
25. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma.
Suvas S; Singh V; Sahdev S; Vohra H; Agrewala JN
J Biol Chem; 2002 Mar; 277(10):7766-75. PubMed ID: 11726649
[TBL] [Abstract][Full Text] [Related]
26. PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma.
Miyoshi H; Kiyasu J; Kato T; Yoshida N; Shimono J; Yokoyama S; Taniguchi H; Sasaki Y; Kurita D; Kawamoto K; Kato K; Imaizumi Y; Seto M; Ohshima K
Blood; 2016 Sep; 128(10):1374-81. PubMed ID: 27418641
[TBL] [Abstract][Full Text] [Related]
27. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
28. Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68+ Cells during Chronic HBV Infection.
Said EA; Al-Reesi I; Al-Riyami M; Al-Naamani K; Al-Sinawi S; Al-Balushi MS; Koh CY; Al-Busaidi JZ; Idris MA; Al-Jabri AA
PLoS One; 2016; 11(6):e0158265. PubMed ID: 27348308
[TBL] [Abstract][Full Text] [Related]
29. Costimulatory molecules in human periodontal disease tissues.
Gemmell E; McHugh GB; Grieco DA; Seymour GJ
J Periodontal Res; 2001 Apr; 36(2):92-100. PubMed ID: 11327084
[TBL] [Abstract][Full Text] [Related]
30. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.
Peach RJ; Bajorath J; Naemura J; Leytze G; Greene J; Aruffo A; Linsley PS
J Biol Chem; 1995 Sep; 270(36):21181-7. PubMed ID: 7545666
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia/lymphoma.
Takeuchi M; Miyoshi H; Nakashima K; Kawamoto K; Yamada K; Yanagida E; Muta H; Moritsubo M; Umeno T; Suzuki T; Seto M; Ohshima K
Ann Hematol; 2020 May; 99(5):1093-1098. PubMed ID: 32157421
[TBL] [Abstract][Full Text] [Related]
32. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
Lane P
Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
[TBL] [Abstract][Full Text] [Related]
33. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
Murata K; Dalakas MC
Am J Pathol; 1999 Aug; 155(2):453-60. PubMed ID: 10433938
[TBL] [Abstract][Full Text] [Related]
34. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process.
Agostini C; Trentin L; Perin A; Facco M; Siviero M; Piazza F; Basso U; Adami F; Zambello R; Semenzato G
Am J Physiol; 1999 Aug; 277(2):L240-50. PubMed ID: 10444517
[TBL] [Abstract][Full Text] [Related]
35. Molecular and Cellular Functions of CTLA-4.
Van Coillie S; Wiernicki B; Xu J
Adv Exp Med Biol; 2020; 1248():7-32. PubMed ID: 32185705
[TBL] [Abstract][Full Text] [Related]
36. Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patients.
Martínez-Escribano JA; Hernández-Caselles T; Campillo JA; Campos M; Frías JF; García-Alonso A; Alvarez-López MR
Hum Immunol; 2003 Aug; 64(8):796-801. PubMed ID: 12878358
[TBL] [Abstract][Full Text] [Related]
37. Costimulatory receptors in the channel catfish: CD28 family members and their ligands.
Quiniou SMA; Bengtén E; Boudinot P
Immunogenetics; 2024 Feb; 76(1):51-67. PubMed ID: 38197898
[TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide causes atrophy of Peyer's patches and an increased expression of CD28 and B7 costimulatory ligands.
Manhart N; Vierlinger K; Habel O; Bergmeister LH; Götzinger P; Sautner T; Spittler A; Boltz-Nitulescu G; Marian B; Roth E
Shock; 2000 Oct; 14(4):478-83. PubMed ID: 11049113
[TBL] [Abstract][Full Text] [Related]
39. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
Taylor-Robinson AW; Smith EC
Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
[TBL] [Abstract][Full Text] [Related]
40. CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common co-signals induced by CD80 and CD86.
Cefai D; Cai YC; Hu H; Rudd C
Int Immunol; 1996 Oct; 8(10):1609-16. PubMed ID: 8921441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]